|
AstraZeneca PLC (, ), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the merger of Swedish Astra AB and British Zeneca Group. AstraZeneca develops, manufactures, and sells pharmaceuticals to treat disorders in the gastrointestinal, cardiac and vascular, neurological and psychiatric, infection, respiratory, pathological inflammation and oncology areas. Sales in 2005 totalled $23.95 billion, with a profit before tax of $6.5 billion. Total R&D spending was $3.4 billion. The corporate headquarters are in London, UK, the research and development (R&D) headquarters are in Södertälje, Sweden. Major R&D centres are located on three continents in the United States, United Kingdom, Sweden, and India. The current chief executive of AstraZeneca is David Brennan. He replaced Sir Tom McKillop on January 1, 2006.
Corporate structure Current members of the board of directors of AstraZeneca are: Peter Bonfield, David Brennan, John Buchanan, Jane E. Henney, Michele Hooper, Joe Jimenez, Tom McKillop, Håkan Mogren, Erna Möller, Bridget Ogilvie, John Patterson, Louis Schweitzer, Jonathan Symonds, and Marcus Wallenberg. Merger and acquisition activity AstraZeneca has, following a collaborative relationship begun in 2004, commenced the acquisition of Cambridge Antibody Technology (CAT). The company is currently in the final stages of exercising compulsory acquisition options against outstanding CAT shares. Collaborations and alliances Diversity In the US, AstraZeneca is one of the 100 Best Companies for Working Mothers in 2004 according to Working Mothers magazine. AstraZeneca and Breast Cancer AstraZeneca is the major sponsor for Breast Cancer Awareness Month which focuses on early detection and treatment*. AstraZeneca is also a leading producer of breast cancer treatment drugs like Tamoxifen and Arimidex Major products AstraZeneca specialises in prescription medicines to fight disease in the several therapeutic areas. Year-on sales information can be found through AstraZeneca annual reports. The following is a list of key products as found on the AstraZeneca website, retrieved 2005-03-27. See also Notes | |||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||
 |
|
| |